Log In
Print this Print this

CMV vaccine (1492903) (GSK1492903)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCytomegalovirus (CMV) vaccine with recombinant glycoprotein B antigen
Molecular Target Human cytomegalovirus (CMV) glycoprotein B
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent congenital transmission of cytomegalovirus (CMV)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today